According to recent research, nasal insulin may have a positive effect on the cognitive function of people with dementia, including Alzheimer’s disease.
Scientists have discovered that insulin receptors are located not only in body tissues, but also in various parts of the brain, demonstrating the potential effect of insulin on cognitive abilities.
Research has also shown that insulin can modulate processes that promote neuronal survival.
The new method of nasal drug delivery opens up opportunities for other drugs as well. Recent experiments have shown that using this method, monoclonal antibodies can be successfully delivered to the brains of post-stroke mice without affecting their efficacy.
These results not only offer new ways to treat patients with dementia, but also offer hope for developing innovative treatments for other diseases and conditions. Additional studies are planned in the future to better understand the interaction between insulin and higher nervous activity.
Source: Ferra
I am a professional journalist and content creator with extensive experience writing for news websites. I currently work as an author at Gadget Onus, where I specialize in covering hot news topics. My written pieces have been published on some of the biggest media outlets around the world, including The Guardian and BBC News.
